Related Experiment Video
Updated: Jun 22, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Heterobiaryl human immunodeficiency virus entry inhibitors.
Rong-Jian Lu1, John A Tucker, Jason Pickens
1Trimeris, Inc, Morrisville, North Carolina 27560, USA. rongjian.lu@sequoiapharma.com
Journal of Medicinal Chemistry
|June 19, 2009
Summary
Researchers discovered new HIV entry inhibitors by replacing indole rings with heterobiaryl groups. These potent compounds show promise for developing novel HIV treatments by targeting the gp120 binding site.
Area of Science:
- Medicinal Chemistry
- Virology
- Drug Discovery
Background:
- Previous HIV attachment inhibitors utilized indole or azaindole scaffolds linked to benzoylpiperazine.
- These compounds targeted the human immunodeficiency virus (HIV) attachment step in its lifecycle.
Purpose of the Study:
- To discover novel potent HIV entry inhibitors.
- To explore alternative scaffolds to indole/azaindole for HIV inhibitor design.
- To investigate structure-activity relationships of new biaryl HIV inhibitors.
Main Methods:
- Synthesis of novel heterocyclic compounds.
- Antiviral assays using pseudotyped viruses to determine inhibitory concentrations (IC50).
- Evaluation against clinical viral isolates for potency and selectivity.
- Structure-activity relationship (SAR) studies.
Main Results:
- A new series of potent HIV entry inhibitors featuring a heterobiaryl group was discovered.
- Several analogues demonstrated IC50 values below 5 nM.
- Compound 13k exhibited potency and selectivity comparable to existing inhibitors against clinical isolates.
- SAR studies suggested a potential binding crevice around the biaryl moiety in the gp120 binding site.
Conclusions:
- The study identified novel heterobiaryl HIV entry inhibitors with significant potency.
- Findings indicate flexibility in HIV inhibitor structure-activity relationships.
- The results suggest new strategies for designing next-generation gp120 inhibitors.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...